AnalystBook Research · Company Intelligence

Hercules Capital, Inc.

HCXYNYSE

Built from Hercules Capital, Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Net income increased 29.2% to $339.7M, while Operating cash flow decreased 260.6% to ($425.8M).

The read at a glance✓ Audited against SEC data
  • ScaleFY2025 revenue N/AOK
  • ProfitabilityNet income $339.7MOK
  • Cash generationFree cash flow ($425.9M)Note
  • AccountingNo applicable forensic screenNote
  • Insiders23 buys; 0 sells in 365 daysOK
  • Capitaldividends paid were $326.0M; share repurchases were $6.5MNote

Business

Hercules Capital, Inc.: Business GENERAL Hercules Capital, Inc. is a specialty finance company focused on providing senior secured loans to high-growth, innovative venture capital-backed and institutional-backed companies in a variety of technology and life sciences industries.

Leadership changes

From Hercules Capital, Inc.'s own filings, the day they're filed.

  • Seth H. Meyer · Chief Financial Officer · departureeff. 2026-05-18
  • Scott Bluestein · Chief Executive Officer · appointmenteff. 2026-04-23
  • Andrew Olson · Chief Financial Officer · appointmenteff. 2026-04-23

Latest filings

  • 10-Q · Quarterly report2026-07-30
  • 8-K · Company announcement2026-07-30
  • 8-K · Company announcement2026-07-24
  • 8-K · Company announcement2026-07-21
  • 8-K · Company announcement2026-06-18
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Hercules Capital, Inc., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.